TALAT GHAUS: Open Payments
NPI 1689623472 · HINSDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 23 payments from 10 companies in 2025. Trend: 2023 $746 · 2024 $301 · 2025 $656
Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $196 |
| Supernus Pharmaceuticals, Inc. | 5 | $150 |
| ABBVIE INC. | 5 | $115 |
| Lundbeck LLC | 2 | $49 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| LivaNova USA, Inc. | 1 | $27 |
| Almatica Pharma LLC | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: SPRAVATO, Qelbree, VRAYLAR, REXULTI, Auvelity, TRINTELLIX, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, LOREEV XR.
Industry payments across IL — which companies pay providers there.
